Treatment of chronic chalazion and hordeolum with botulinum toxin

Details for Australian Patent Application No. 2004216901 (hide)

Owner Botulinum Toxin Research Associates, Inc.

Inventors Borodic, Gary E.

Agent FB Rice

Pub. Number AU-B-2004216901

PCT Pub. Number WO2004/078199

Priority 60/453,029 06.03.03 US

Filing date 8 March 2004

Wipo publication date 16 September 2004

Acceptance publication date 12 November 2009

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 17/08 (2006.01) Drugs for dermatological disorders

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078199 Priority application(s): WO2004/078199

12 November 2009 Application Accepted

  Published as AU-B-2004216901

11 March 2010 Standard Patent Sealed

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216904-Treatment of sinusitis related chronic facial pain and headache with botulinum toxin

2004216900-An accessory for a ball game